DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 37 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $613,012 | +82294.1% | 159,224 | -35.4% | 0.00% | – |
| Q1 2023 | $744 | -25.7% | 246,317 | -49.6% | 0.00% | -100.0% |
| Q4 2022 | $1,002 | -99.9% | 488,783 | +54.0% | 0.00% | 0.0% |
| Q3 2022 | $1,098,000 | -6.6% | 317,292 | +13.6% | 0.00% | 0.0% |
| Q2 2022 | $1,176,000 | +888.2% | 279,372 | +615.0% | 0.00% | – |
| Q1 2022 | $119,000 | -33.9% | 39,074 | +1.1% | 0.00% | – |
| Q4 2021 | $180,000 | -39.4% | 38,656 | +0.3% | 0.00% | – |
| Q3 2021 | $297,000 | -50.6% | 38,536 | -44.9% | 0.00% | – |
| Q2 2021 | $601,000 | -63.1% | 69,917 | -51.3% | 0.00% | -100.0% |
| Q1 2021 | $1,630,000 | – | 143,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $27,001,000 | 4.71% |
| Samsara BioCapital, LLC | 826,422 | $7,107,000 | 0.88% |
| Orbimed Advisors | 4,945,192 | $42,529,000 | 0.43% |
| Foresite Capital Management IV, LLC | 297,711 | $2,560,000 | 0.35% |
| Alphabet Inc. | 1,636,258 | $14,072,000 | 0.29% |
| Casdin Capital, LLC | 1,171,421 | $10,074,000 | 0.26% |
| HARVARD MANAGEMENT CO INC | 328,798 | $2,828,000 | 0.16% |
| Tibra Equities Europe Ltd | 43,400 | $373,000 | 0.12% |
| AlphaCentric Advisors LLC | 45,000 | $387,000 | 0.10% |
| Bronte Capital Management Pty Ltd. | 159,462 | $1,371,000 | 0.10% |